Detailed description of cellular models and culture conditions used in this study ( Figure S10 ): EpH4, a murine mammary epithelial cell line spontaneously immortalized from mid-pregnant mice, undergoes complete epithelial polarization in cell culture, either on porous supports or in serum-free 3D collagen-I gels, where these cells form organotypic, tubular structures. TGFβ treatment causes cell cycle arrest and apoptosis in EpH4 (Grunert et al, 2003; Huber et al, 2005) cells. After transformation with oncogenic Ha-RasV12 -which hyperactivates both the MAPK-and PI3K pathways -the resulting EpRas cells remain largely epithelial and form alveolar structures with larger lumina in collagen gels, and also show increased proliferation (Grunert et al, 2003; Janda et al, 2002a; Oft et al, 1996) . Upon TGFβ treatment, EpRas cells undergo EMT in collagen gels, leading to a fibroblastoid morphology, high motility and invasive growth within collagen gels.
2
Eger et al, 2000 ; Reichmann et al, 1992) . Stable knockdown of AnxA1 in EpRas and EpC40 cells yielded EpRas-siAnxA1 and EpC40-siAnxA1 cells, which showed a similar, fibroblastoid EMTphenotype as EpRasXT cells (Figs. S10B-1,B-2). All EpH4-derived cells were cultivated in DMEM/F12 medium (GIBCO) plus 10% fetal bovine serum (FCS), 100 U/ml penicillin and 50µg/ml streptomycin, 1mM HEPES, 2mM L-glutamine. However, for cultivation of EpRas cells FCS was reduced to 4%, while EpRasXT cells were kept in medium with 15%FCS. To guarantee similar culture conditions of all cells used to produce culture supernatants for analysis of secreted factors, cells were cultivated overnight in media without serum and supernatants concentrated by ultrafiltration.
As a control experiment for potential off-target effects of AnxA1 knockdown in EpC40 cells, we retrovirally expressed full-length human AnxA1 cDNA in EpC40-siAnxA1 cells using a GFPcontaining retroviral vector. GFP positive EpC40-siAnxA1+hAnxA1 cells showed enhanced AnxA1 expression (Fig. S2C ) and were reversed to an epithelial phenotype (Fig. S2C, D) .
The human mammary carcinoma cell lines BT474, MCF7, T47D, ZR751, SKBR3, HS578T and MDA-MB-231 (Fig. S10A-4) are described in detail in (Eger et al, 2005) . While BT474, MCF7 and T47D form a cobblestone-like, epitheloid monolayer on plastic, express Ecadherin and lack the E-cadherin repressor deltaEF1, the cell lines SKBR3, HS578T and MDA-MB-231 have fibroblastoid morphology, lack E-cadherin and express high levels of deltaEF1. The cell line ZR751 grows in clumps of rounded cells with low adherence, but expresses E-cadherin and lacks deltaEF1 (Eger et al, 2005) . These cells were grown in the same medium as EpH4 cells. The cell lines MDA-MB-231-empty and MDA-MB-231+AnxA1 were cultivated in medium containing 4%FCS.
Various HMEC-derivatives, kindly provided by Dr. William Hahn (Zhao et al, 2003) , were grown in a special, serum-free medium (human mammary epithelial cell growth medium containing a supplement mix; MEGM, Promocell). The HMEC-derivatives used expressed SV40 large T (LT) plus SV40 small T (sT) (HMEC-hTert/LT/sT), oncogenic HaRas plus SV40 large T (HMEChTert/Ras/LT) or co-expressed all three oncogenes (HMEC-hTert/Ras/LT/sT), respectively.
The MDCK-DDRafER cell line, originally obtained from J. Downward (Lehmann et al, 2000) was optimized by cloning to resemble the original, fully polarized MDCK cells in absence of ligands (Tanos & Rodriguez-Boulan, 2008) . Cells were grown in DMEM/F12 plus 10% FCS. For EMT-induction, the cells were seeded and maintained on plastic at semi-confluent density and treated or not treated with 3x10 -6 M estradiol (E2) for 2 days. Cells were then trypsinized, re-seeded at near confluency on porous supports (translucent filters with 1.5 µm mean pore size, 1.7 or 4.5 cm in diameter) and treated or not treated with E2 plus 3ng/ml TGFβ1 for 4-5 days, during which time untreated cells got dense enough to fully polarize (as shown with apical markers and Z-stack analysis, not shown). Treatment with drugs or inhibitors was performed while the cells were expanding for 4-5 days on filters.
Tissue collections and databases used for analysis of endogenous AnxA1 levels:
Human breast cancer tissue samples ( Fig personnel (Ferby et al, 2006) , who provided us with the graph in Fig. S1A , which depicts data from evaluating Affymetrics chips containing probes for essentially all human genes and hybridized with probes from >10 different human carcinoma types prepared from 20 to >100 tissue samples from cancer patients as well as normal tissues. The data shown in Fig. S1A All procedures were performed according to Gateway protocol's instructions (Invitrogen).
The following two different oligonucleotides were selected for RNAi of murine AnxA1:
5´AGGGTAGGGGCTCACTGCTGACCCAGGA3`
5´GGAGACCATAAT CCTGATCAATGCCTTA3`, annealed with respective, second oligonucleotides and the resulting, double-stranded shRNA fragments were inserted into the gateway-compatible pSHAG vector (Paddison et al, 2002) according to the Gateway protocol's instructions (Invitrogen). The resulting U6-promoter-driven shRNAs were then transferred to the pMSCV-pgk-puromycin retroviral vector (Clontech) by recombination, according to Gateway protocols instructions. A basic BLAST alignment search of all target sequences did not reveal significant sequence homology with other genes. All shRNAexpressing vectors were confirmed by sequence analysis of the target insert. Vectors containing 28nt target sequence for human AnxA1 were generated as described above for the mouse constructs, selecting three oligonucleotide sequences:
To generate retroviral vectors expressing human AnxA1, we PCR-amplified full length
AnxA1 from a cDNA library. This DNA was inserted into the p201 gateway donor vector and then subcloned into two different target vectors by recombination according to the gateway protocol (Invitrogen): the pMSCV-pgk-puromycin vector to infect MDA-MB-231 cells and the pMSCV-GFP target vector to infect the already puro-resistant EpC40-siAnxA1 cells. The insert was confirmed by sequencing using specific primers in both constructs.
Generation of stable cell lines expressing the above retroviral vector:
Retrovirus producer cell lines (NIH-3T3gp+86 cells) were transfected with the above retroviral constructs using Lipofectamine2000 reagent (Invitrogen). These producer cells were seeded into 6-well plates (4.5 ml medium) at densities allowing generation of semiconfluent cell layers at three consecutive days. Twice daily, supernatants were harvested from producer cells having the correct density, filtered through a 0.45 µm filter and used to infect target cells in the presence of polybrene (2µg/ml) by respective medium changes. 
Antibodies and pharmacological inhibitors:
The following antibodies were used in Western Blot-and immunofluorescence analysis (Catalogue Nr's and working dilutions in brackets). Antibodies against EGFR (sc-31155 and sc-03; 1:1000), AnxA1 (sc-11387, 1:1000), AnxA5 (sc-8300; 1:1000), AnxA6 (sc-11388; 1:1000) and AnxA7 (sc-11389; 1:1000) were from Santa Cruz. Antibodies to AnxA2 (610068; 1:1000) and AnxA4 (610294; 1:1000) were from BD Transduction Laboratories. Antibody to N-cadherin (33-3900; 1:1000) was from Zymed and antibodies to Vimentin (V 5255; 1:500), β-actin (A 2066¸ 1:500), pErk1/2 (M 8159; 1: 40000) and total Erk1/2 (M 5670; 1:20000) were from Sigma.
Antibodies to the total-and serine-phosphorylated proteins Stat3 (9132, 9135; 1:500), Smad2
(3102, 3101; 1:1000), AKT (9270, 9268; 1:1000), p38MAPK (9212, 9211; 1:1000) were from Cell
Signaling. The E-cadherin antibody (610181; 1:1000) was from Becton Dickinson (BD).
Phosphorylation of the EGFR was detected after immunoprecipitation with an EGFR specific antibody (sc-03), using the 4G10 antibody from Millipore (05-321; 1:1000). The TGFβ1 antibody was from Promega (G 1221; 1:500). The antibody used for detecting AnxA1 by immunofluorescence (1:500) and immunohistochemistry (IHC) (1:1500) was from Becton Dickinson (BD; 610067).
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The pan-Jak inhibitor I (2µM, inhibiting Jak1, Jak2, Jak3 leading to a complete response were determined earlier on cell types known to respond to the above inhibitors against p38MAPK (Maschler et al, 2004) , PI3K, MEK, and RAS (Janda et al, 2002a; Janda et al, 2002b) ; TGFβRI (Waerner et al, 2006) and Jak inhibitor I (Grebien et al, 2008) .
Detailed procedure for Western Blot analysis:
For Western Blot (WB) analysis, cells were lysed on ice for 20 min in ice-cold RIPA buffer, containing 150mM NaCl, 50mM Tris pH 7.4, 1% NP40, 1% Na-desoxycholate, 1mM Na 3 VO 4 , 25mM NaF, 1mM PMSF, 5mM β-glycerol-phosphate, 10mM DTT, protease inhibitor cocktail tablets (Complete mini; Roche, according to manufacturer`s instructions). Lysates were cleared for 5 min at 12500xg and 4°C and protein concentrations determined using the Bradford assay (Biorad). 40µg of protein were denatured in SDS-sample buffer, followed by SDS-PAGE and transferred to PVDF membranes. After treatment with blocking solution (5% bovine serum albumin (BSA) in TBST; i.e. Tris-buffered saline + Tween 20), membranes were incubated with the respective antibody in blocking solution for 1hr at room temperature or over night at 4°C, washed with plain TBST and incubated with the respective secondary antibody in blocking solution for 1hr
at room temperature. After 5 washes with TBST for 30 min, the blots were developed using an enhanced chemiluminescence kit (ECL, Amersham). Quantitation of WB data from human breast carcinoma cells analysed for AnxA1 protein expression was performed by densitometry, using
ImageJ software according to the manufacturers instructions, using loading control data (β-actin)
for normalization.
Immunoprecipitation of cell surface-and metabolically labelled proteins: detailed procedure:.
For exclusive labelling of cell surface proteins, cell surface biotinylation was performed as described previously (Maschler et al, 2005) with minor modifications. Briefly, cells were detached by trypsinisation, washed in Hank`s balanced salt solution (HBSS) and biotinylated at 2x10 6 cells per ml for 30 min, using 1mg/ml Sulfo-NHS-Biotin (Sigma) in HBSS. After stopping the biotinylation reaction with DMEM containing 0.6 % bovine serum albumin (BSA) for 10 min, cells were washed extensively in HBSS and lysed in 50mM Tris (pH 7.5), 0.1% Triton X100, 50mM
NaCl. Equal amounts of protein were immunoprecipitated with the respective antibody for 1 hour and immune complexes collected using Protein A/G plus beads (Santa Cruz). The immunoprecipitates (removed from beads with SDS sample buffer) were subjected to SDS-PAGE, transferred to nitrocellulose membranes (Amersham) and incubated with blocking solution (see Western Blot) at 50°C for 1 hour. Biotinylated proteins were detected by treating the membrane with streptavidine-horse radish peroxidase (Sigma, 1:5000 in 1%BSA for 1hr at room temperature) and visualized using ECL-detection reagent.
For metabolic labelling, equal cell numbers were plated on 10 cm plastic dishes in 10 ml medium at 1-3 x10 6 cells/dish and pre-incubated with methionine and cysteine-free MEM (GIBCO) for 1hr, then labelled with 100µCi of [ 35 S]-L-methionine/L-cysteine (MP Biomedicals) in 10 ml of the above medium for 5hr and lysed as described for Western blot analysis. Aliquots of cell lysates were cleared by centrifugation and aliquots containing 2 x 10 6 cpm of incorporated [
35 S] were subjected to immunoprecipitation with appropriate antibodies. Precipitated proteins were subjected to SDS-PAGE. Gels were fixed in 7% acetic acid, 25% methanol in aqua dest. for 30 min, treated with ENHANCE amplifier solution (NEN), dried and exposed for autoradiography on Kodak X-ray film in enhancer screen cassettes.
Collagen gel culture methods and immunofluorescence analysis:
For successful 3D culture of MDA-MB-231 cells in collagen gels, we optimized the cell numbers seeded (between 1000 and 3000 cells per gel). TGFβ was added 2 days after seeding where indicated, while pharmacological inhibitors were added 1 day after seeding. Depending on 8 the growth rate of the collagen structures, gels were maintained for 7-10 days, after which they were photographed, fixed and processed for antibody staining.
Non-Permeant cellular ELISA: details and minor modifications:
Cell surface EGFR was determined using a non permeant cellular ELISA assay described in (Lee et al, 2002) with minor modifications. Briefly, 1x10 4 cells were seeded into 12-well plates in 1.5 ml medium and cultivated for 24 hours. Cells were then fixed with 4% paraformaldehyde in 50mM phosphate buffer (pH 7.2) for 20min at room temperature. Cells were washed three times with ice cold PBS containing 0.1M glycine and incubated with 3% H 2 O 2 in PBS for 5 minutes to minimize endogenous peroxidase activity. After blocking with 5%FCS+1% BSA in PBS for 30 minutes, cells were incubated for 1 hour at room temperature with the primary anti-EGFR-antibody (Santa Cruz, sc-03, 1µg/ml in blocking solution), subsequently washed three times with ice cold PBS and treated with the peroxidase conjugated secondary antibody. Then cells were washed and the colour reaction was carried out with the substrate solution of the IL6 ELISA kit. The coloured reaction end product was transferred to a microtiter plate and stop solution (from the IL6 ELISA kit) was added. After 30min, the colour reaction was measured with an ELISA reader at 450nm, using 570nm as the control wavelength.
Analysis of AnxA1 expression in human tissue tumor arrays by immunohistochemistry:
Slides bearing 3 µm sections from two human breast cancer tissue tumor arrays (TA2, TA3) using primary tumor tissue from 141 patients with known disease history were dried at 65°C for 45 minutes, deparaffinated by washing with xylene three times followed by incubation in 100% and 50% ethanol. Antigen retrieval was performed by incubating the slides in antigen retrieval buffer (DAKO S1699) for 30minutes at 95°C. After the slides were allowed to cool down they were washed once in 1xPBS and incubated in blocking solution (15% goat serum / PBS) for 15 minutes.
Primary antibody (anti-AnxA1; Becton Dickinson; BD 610067) was added at a dilution of 1:1500 in 1%BSA / PBS and slides were incubated for 60 minutes. Endogenous peroxidase was blocked by treating the samples with 0.3% H 2 O 2 / PBS for 20minutes. After washing 3 times with 1xPBS the secondary antibody (biotinylated, DAKO E0413) was added at a dilution of 1:500 in 1%BSA / PBS and the samples were incubated for 30minutes followed by three washing steps with PBS. The streptavidine-biotin complex (DAKO K0377) was added for 30 minutes. Then the slides were washed three times in PBS and colour development was carried out in AEC (1% w/v 3,3-amino-9-ethyl-carbazole; Sigma 5754 in N, N-dimethylformamide). Counter-stain was performed with Hematoxylin (Sigma MHS-16). The slides were then washed in tap water, dried for 15minutes and mounted in mounting medium (Aquatex, Merck 1.08562) and analysed by high resolution imaging (MIRAX-software) of the stained arrays. After normalization of staining intensity using Adobe Photoshop CS4 (Waerner et al, 2006) , using blue nuclear and cytoplasmic staining for normalization, intensity and subcellular localization of the brown AnxA1 signal was recorded and correlated in Kaplan-Meier plots to metastasis free survival and overall survival (Waerner et al, 2006) , using the available patient disease history information.
RNA Isolation and cDNA synthesis:
Total RNA was isolated using the TRIzol Reagent (Invitrogen) according to the manufacturer's instruction. cDNA was synthesized from 2µg of total RNA using the "Ready to go you prime First Strand" beads kit (Amersham Biosciences) and random oligonucleotides according to the manufacturer`s instruction.
qRT-PCR of AnxA1 levels in cell lines and tumor tissues:
RNA was prepared from cell pellets containing 1-2x10 8 cells or from tumor tissues according to standard procedures. qRT-PCR of the expression levels of AnxA1 in these RNA samples was performed using the SYBR green 2x PCR kit (Applied Biosciences) and a primer mix from Qiagen and were normalized to GAPDH levels.
qRT-PCR of E-cadherin repressor in cell lines:
1µl of cDNA was used per reaction, which was performed using SYBR Green (Molecular Probes) and an Opticon2 Monitor Fluorescence Thermocycler in a 25µl reaction volume for 40 cycles. Comparable Ct (cycle threshold) method was used to quantify the amplified fragments and RNA expression levels were normalized to GAPDH.
Tumor formation and metastasis assay: minor modifications and details:
Tumor formation ability was determined by mammary gland fat pad or subcutanous injection as described earlier (Jechlinger et al, 2002; Maschler et al, 2005; Zhao et al, 2003) , with minor Neu) were maintained separated from males until tumors developed (6-9 months). Tumors were snap frozen in liquid nitrogen and kept at -80°C. For histology and expression of EMT-markers in these tumors, see (Jechlinger et al, 2006) . For Western Blot analysis, small tumor pieces were lysed in RIPA buffer using a homogenizer and lysates were then subjected to SDS-PAGE (see main text, 
